glp 1 agonist vs sglt2 inhibitor GLP1 Receptor Agonists SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Metabolic Powerhouses: GLP-1 RAs and
Description
What is Liraglutide (Victoza, Saxenda) and its mechanism of action
The first goal of these trials was to prove GLP-1 receptor agonists cardiovascular safety, and majority of CVOTs were designed as non-inferiority trials
However, there is lack of RCTs in T1D using the newest generation of GLP-1RA or dual GLP-1/GIP agonists, which are associated with significantly more weight loss
2020 Sep;11(9):1965-1982
Plum A, Jensen LB, Kristensen JB
